Cargando…

Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2

3-chyomotrypsin like protease (3CLpro) has been considered as a promising target for developing anti-SARS-CoV-2 drugs. Herein, about 6000 compounds were analyzed by high-throughput screening using enzyme activity model, and Merbromin, an antibacterial agent, was identified as a potent inhibitor of 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Junjie, Zhang, Yaya, Zeng, Dequan, Zhang, Bingchang, Ye, Xiaohong, Zeng, Zhiping, Zhang, Xiao-kun, Wang, Zhanxiang, Zhou, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716398/ https://www.ncbi.nlm.nih.gov/pubmed/35007835 http://dx.doi.org/10.1016/j.bbrc.2021.12.108

Ejemplares similares

Development of an Immune-Related Prognostic Index Associated With Glioblastoma
por: Jiang, Zhengye, et al.
Publicado: (2021)

Association between chronic periodontitis and the risk of Alzheimer’s disease: combination of text mining and GEO dataset
por: Jiang, Zhengye, et al.
Publicado: (2021)

Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
por: He, Jun, et al.
Publicado: (2020)

Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
por: Li, Daoqun, et al.
Publicado: (2021)

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest
por: Zhao, Wenpeng, et al.
Publicado: (2023)

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2022)

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2023)

Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
por: Zhang, Huijun, et al.
Publicado: (2023)

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
por: Zang, Yi, et al.
Publicado: (2022)

In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
por: Huynh, Tien, et al.
Publicado: (2021)

Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2022)

Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)

Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
por: Shan, Hengyue, et al.
Publicado: (2021)

Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone
por: Jiang, Haihai, et al.
Publicado: (2022)

Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?
por: Maiti, Biplab K
Publicado: (2020)

Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
por: Li, Qingxin, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
por: Elseginy, Samia A., et al.
Publicado: (2021)

Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease
por: Li, Dongsheng, et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

An electrochemical biosensor for SARS-CoV-2 detection via its papain-like cysteine protease and the protease inhibitor screening
por: Liang, Qizhi, et al.
Publicado: (2023)

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
por: Jiang, Xiangrui, et al.
Publicado: (2023)

Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease
por: Bosken, Yuliana K., et al.
Publicado: (2020)

Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
por: Kumar, Vathan, et al.
Publicado: (2016)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
por: Liu, Zhongli, et al.
Publicado: (2022)

SARS-CoV-2 Papain-Like Protease Potential Inhibitors—In Silico Quantitative Assessment
por: Stasiulewicz, Adam, et al.
Publicado: (2021)

Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease
por: Li, Lingyu, et al.
Publicado: (2022)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
por: Lim, Chew Theng, et al.
Publicado: (2021)

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
por: Hersi, Fatema, et al.
Publicado: (2023)

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
por: Osipiuk, Jerzy, et al.
Publicado: (2021)

Downregulation of phosphoglycerate mutase 5 improves microglial inflammasome activation after traumatic brain injury
por: Chen, Yuhua, et al.
Publicado: (2021)

Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
por: Lee, Hyun, et al.
Publicado: (2015)

U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways
por: Xu, Yang, et al.
Publicado: (2014)

Crystal structure of SARS-CoV 3C-like protease with baicalein
por: Feng, Jingwen, et al.
Publicado: (2022)

Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021)

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
por: Chiou, Wei-Chung, et al.
Publicado: (2021)

Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease
por: Eberle, Raphael J., et al.
Publicado: (2023)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
por: Zhang, Wenfa, et al.
Publicado: (2023)

New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)

Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan
por: Zhang, Yun, et al.
Publicado: (2014)

The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate
por: Wang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fo5g3anh9343rfbv8c466g8j2j